0000950170-24-004786.txt : 20240117 0000950170-24-004786.hdr.sgml : 20240117 20240116191447 ACCESSION NUMBER: 0000950170-24-004786 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240111 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240117 DATE AS OF CHANGE: 20240116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Carmell Corp CENTRAL INDEX KEY: 0001842939 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40228 FILM NUMBER: 24536461 BUSINESS ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 646-494-3296 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Carmell Therapeutics Corp DATE OF NAME CHANGE: 20230727 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA HEALTHCARE ACQUISITION CORP III DATE OF NAME CHANGE: 20210127 8-K 1 ctcx-20240111.htm 8-K 8-K
false000184293900018429392024-01-112024-01-110001842939us-gaap:CommonStockMember2024-01-112024-01-110001842939ctcx:CommonStockWarrantsMember2024-01-112024-01-11

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 11, 2024

 

 

Carmell Corporation

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40228

86-1645738

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

2403 Sidney Street, Suite 300

 

Pittsburgh, Pennsylvania

 

15203

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 281 297-8276

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

CTCX

 

The Nasdaq Stock Market LLC

Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50

 

CTCXW

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 8.01 Other Events.

 

On January 11, 2024, Carmell Corporation ("Company") issued a press release announcing the addition of Dr. Sean Kelishadi to the Company's Scientific Advisory Board. A copy of the press release is provided as Exhibit 99.1 to this Current Report.

 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

The following exhibit is filed as part of this report:

 

Exhibit

Number Description

 

99.1 Press Release Announcing Addition of Dr. Sean Kelishadi to Scientific Advisory Board, dated January 11, 2024

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

Date:

January 16, 2024

By:

/s/ Bryan J. Cassaday

 

 

 

Bryan J. Cassaday
Chief Financial Officer

 

 EX-99.1 2 ctcx-ex99_1.htm EX-99.1 EX-99.1

Carmell Corp Announces Addition of Dr. Sean Kelishadi to Scientific Advisory Board

 

 

PITTSBURGH, USA, January 11, 2024 /EINPresswire.com/ -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell” or the “Company”), today announced the addition of Dr. Sean Kelishadi to their Scientific Advisory Board.

 

Dr. Kelishadi is a Board-Certified Plastic Surgeon who owns and operates his private practice in Newport Beach, CA. He is approved by the American Society for Aesthetic Plastic Surgery (ASAPS) as a Fellowship Director to train the next generation of clinical leaders. Dr. Kelishadi has delivered 26 lectures at conferences such as the American Society of Plastic Surgeons Meeting, The American Society for Aesthetic Plastic Surgery Meeting, Plastic Surgery Research Council, American Transplant Congress among others. Dr. Kelishadi has published 37 peer reviewed papers in journals such as the Aesthetic Surgery Journal, Journal of Clinical Investigation, Plastic and Reconstructive Surgery Journal, Aesthetic Surgery Journal Open Forum, ePlasty, Transplantation, Annals of Plastic Surgery, and other journals. Dr. Kelishadi has also presented 51 abstracts covering research topics across wound reconstruction and healing, transplant success and various surgical techniques.

 

Dr. Kelishadi received his undergraduate degree at Vanderbilt University in Nashville and his medical degree from University of Tennessee-Memphis College of Medicine followed by his general surgery residency at the University of Maryland and the prestigious Shock Trauma Center in Baltimore, MD. While at Baltimore, he also spent 2 years performing NIH funded research on groundbreaking mechanisms in immunobiology. Later, he completed his plastic surgery residency at the University of Louisville, KY.

 

Said Mr. Rajiv Shukla, Chairman & CEO of Carmell, “As a peer reviewer for The Aesthetic Surgery Journal, Dr. Kelishadi is deeply involved in studying the latest scientific developments in the aesthetics industry. His track record as an elite clinician combined with a stellar research background makes him a real asset to our SAB.”

 

Said Dr. Kelishadi, “I have closely followed the application of regenerative science, as a clinician and a researcher, to help my patients achieve superior treatment outcomes. In my view, Carmell’s Secretome platform represents the future of bio-aesthetics with its clinically validated technology. It is an honor to join forces with my fellow physicians who are the leaders of this movement to help build Carmell.”

 

About Carmell

Carmell is a bio-aesthetics company that utilizes the human platelet secretome to topically deliver more than a thousand proteins and growth factors to support skin and hair health. Carmell’s quality ethos is based on rational cosmetics design coupled with a focus on clean formulas that omit 14 commonly used chemicals that are proven to be adverse to human health. The Company is focused on developing topical cosmetics tailored to meet the demanding technical requirements of professional care providers.

For more information, visit www.carmellcosmetics.com

 

Forward-Looking Statements

This press release contains forward-looking statements that are based on beliefs and assumptions and information currently available. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology. However, not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain. Forward-looking statements in this press release include, but are not limited to, statements about the attributes and benefits of Carmell’s products including R&D products under development. We cannot assure you that the forward-looking statements in this press release will prove to be accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among others, the ability to recognize anticipated benefits from their commercial products, R&D pipeline, distribution agreements, changes in applicable laws or regulations, the possibility that Carmell may be adversely affected by other economic, business, and/or competitive factors, and other risks and uncertainties, including those to be included under the header “Risk Factors” in the 10-Q statement on filed by Carmell with the SEC on November 15, 2023, as amended. Most of these factors are outside of Carmell’s control and are difficult to predict. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame or at all. The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.

 

Bryan Cassaday

Carmell Corporation

bc@carmellcorp.com

 EX-101.SCH 3 ctcx-20240111.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity Ex Transition Period Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications Document Information [Table] Document Information [Line Items] Common Stock Warrants Member Common Stock Warrants [Member] Class of Stock [Axis] Class of Stock [Domain] Common Stock [Member] XML 4 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Document And Entity Information
Jan. 11, 2024
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 11, 2024
Entity Registrant Name Carmell Corporation
Entity Central Index Key 0001842939
Entity Emerging Growth Company true
Entity File Number 001-40228
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 86-1645738
Entity Address, Address Line One 2403 Sidney Street, Suite 300
Entity Address, City or Town Pittsburgh
Entity Address, State or Province PA
Entity Address, Postal Zip Code 15203
City Area Code 281
Local Phone Number 297-8276
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period false
Common Stock [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol CTCX
Security Exchange Name NASDAQ
Common Stock Warrants [Member]  
Document Information [Line Items]  
Title of 12(b) Security Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
Trading Symbol CTCXW
Security Exchange Name NASDAQ
XML 5 ctcx-20240111_htm.xml IDEA: XBRL DOCUMENT 0001842939 2024-01-11 2024-01-11 0001842939 us-gaap:CommonStockMember 2024-01-11 2024-01-11 0001842939 ctcx:CommonStockWarrantsMember 2024-01-11 2024-01-11 false 0001842939 8-K 2024-01-11 Carmell Corporation DE 001-40228 86-1645738 2403 Sidney Street, Suite 300 Pittsburgh PA 15203 281 297-8276 false false false false Common Stock, par value $0.0001 per share CTCX NASDAQ Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 CTCXW NASDAQ true false EXCEL 6 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 3 23 1 false 2 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports ctcx-20240111.htm ctcx-20240111.xsd http://xbrl.sec.gov/dei/2023 false false JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ctcx-20240111.htm": { "nsprefix": "ctcx", "nsuri": "http://www.carmellcorp.com/20240111", "dts": { "inline": { "local": [ "ctcx-20240111.htm" ] }, "schema": { "local": [ "ctcx-20240111.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 1, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 30, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 26 }, "report": { "R1": { "role": "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_9e17d57b-3d7b-4d06-a4ac-b4f333653653", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ctcx-20240111.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_9e17d57b-3d7b-4d06-a4ac-b4f333653653", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ctcx-20240111.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "ctcx_CommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.carmellcorp.com/20240111", "localname": "CommonStockWarrantsMember", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Common Stock Warrants Member", "label": "Common Stock Warrants [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.carmellcorp.com/20240111/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 12 0000950170-24-004786-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-004786-xbrl.zip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end